Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2000-03-07
2010-02-23
Mondesi, Robert B (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S300000, C424S250100, C424S249100, C424S190100, C424S184100, C435S069300, C435S252300, C536S023100, C536S023700, C536S024320
Reexamination Certificate
active
07666988
ABSTRACT:
The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
REFERENCES:
patent: 2005/0191316 (2005-09-01), Fraser et al.
patent: 2007/0026021 (2007-02-01), Fraser et al.
patent: WO96/12020 (1996-04-01), None
patent: WO98/02547 (1998-01-01), None
patent: WO99/24578 (1999-05-01), None
patent: WO99/57280 (1999-11-01), None
patent: WO 00/22430 (2000-04-01), None
patent: WO00/66791 (2000-11-01), None
patent: WO01/85772 (2001-11-01), None
Rudinger et al, in “Peptide Hormones”, edited by Parsons, J.A., University Park Press, Jun. 1976, p. 6).
Burgess et al., The Journal of Cell Biology, 111:2129-2138, 1990.
Lazar et al., Molecular and Cellular Biology, 8(3): 1247-1252, 1988.
Jobling et al. (Mol. Microbiol. 1991, 5(7): 1755-67).
Unanue. ER 1999 , American Journal of Pathology; 154; 651-664).
Infect Immun. Jul. 1998;66(7):3223-31.
Molloy et al (Molecular Immunol. 35, 1998, pp. 73-81).
Arnon et al Faseb J. Nov. 1992; 6(14): 3265-74).
Roitt et al, 1998, Immunology, 4th ed, Mosby, p. 7.7-7.8.
Holmes (Exp. Opin.Invest. Drugs, 2001, 10(3):511-519.
Herbert et al. (The Dictionary of Immunology, Academic Press, 4th edition, 1995, p. 58-59.
Greenspan et al (Nature Biotechnology 7:936-937 (1999).
Bowie et al (Science, 1990, 257:1306-1310.
Coleman et al. (Research in Immunology, 1994; 145(1): 33-36).
Abaza et al. (Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444.
Lederman et al (Molecular Immunology 28:1171-1181, 1991).
Li et al (Proc. Natl. Acad. Sci. USA 77:3211-3214, 1980).
Herbert et al (The Dictionary of Immunology, Academic Press, 3rd Edition, London, 1985, pp. 58.
Martin D et al: “Highly ConservedNeisseria meningitidisSurface Protein Confers Protection Against Experimental Infection” Journal of Experimental Medicine, vol. 185, No. 7, (1997), pp. 1173-1183.
Lissolo L et al: “Evaluation of Transferrin-Binding Protein 2 with the Transferrin Binding Protein Complex as a Potential Antigen for Future Meningococcal Vaccines” Infection and Immunity, vol. 63, No. 3, Mar. 1995, pp. 884-890.
International Search Report from PCT/EP00/01955.
“Selection of Immunogenic Peptides for Antisera Production,”Current Protocols in Immunology, John Wiley & Sons, 1991, units 9.3.1-9.3.5..
Geysen et al., “Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid,”Proc. Nat. Acad. Sci. USA, Jul. 1984, vol. 81, pp. 3998-4002.
Reece et al., “Scanning for T helper epitopes with human PBMC using pools of short synthetic peptides,”Journal of Immunological Methods, 1994, vol. 172, No. 2, pp. 241-254.
Reece et al., “Mapping the Major Human T Helper Epitopes of Tetanus Toxin,”The Journal of Immunology, 1993, vol. 151, pp. 6175-6184.
“Synthesis of Multipe Peptides on Plastic Pins,”Current Protocols in Immunology, John Wiley & Sons, 1997, units 9.7.1-9.7.19.
Niman, et al., “Generation of protein-reactive antibodies by short peptides is an event of high frequency: Implications for the structural basis of immune recognition,”Proc. Natl. Acad. Sci. USA, Aug. 1983, vol. 80, pp. 4949-4953.
Dillner et al., “Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen,” Aug. 1984,Proc. Natl. Acad. Sci. USA, vol. 81, pp. 4652-4656.
Sali et al., “Three-dimensional Models of four Mouse Mast Cell Chymases,”The Journal of Biological Chemistry, vol. 268, No. 12, Apr. 25, 1993, pp. 9023-9034.
Tettelin et al., “Complete Genome Sequence ofNeisseria meningitidisSerogroup B Strain MC58,”Science, vol. 287, Mar. 10, 2000, pp. 1809-1815.
Zhou et al., “On the origin of membrane vesicles in Gram-negative bacteria,”Ferns Microbiology Letter, 163, 1998, pp. 223-238.
Shinnick et al., “Synthetic Peptide Immunogens as Vaccines,”Annual Review Microbiology, 1983, vol. 37, pp. 425-446.
Geysen et al., “Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein,”Proc. Natl. Acad. Sci. USA, vol. 82, Jan. 1985, pp. 178-182.
Roitt et al., “The Structures of Antigens,”Immunology, 3d Edition, 1993, units 7.7-7.8.
Peeters et al., “Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesical vaccine,”Vaccine, vol. 14, No. 10, 1996, pp. 1009-1015.
Claassen et al., “Production, characterization and control of aNeisseria meningitidishexavalent class 1 outer membrane protein containing vesicle vaccine,”Vaccine, vol. 14, No. 10, 1996, pp. 1001-1008. •.
Fredriksen et al., “Production, characterization and control of MenB-vaccine “Folkehelsa”: an outer membrane vesicle vaccine against group B meningococcal disease,”NIPH Annals, vol. 14, No. 2, Dec. 1991, pp. 67-80.
Hopp, “Retrospective: 12 Years of Antigenic Determinant Predictions, and More,”Peptide Research6(4):183-190, 1993.
Jameson et al., “The antigenic index: a novel algorithm for predicting antigenic determinants,”Computer Application Bioscience4(1):181-186, 1988.
Kolaskar et al., “A semi-empirical method for prediction of antigenic determinants on protein antigens,”FEBS276(1,2):172-174, 1990.
Menéndez-Arias et al., “A BASIC microcomputer program for prediction of B and T cell epitopes in proteins,”Comput. Appl. Biosci. 6(2):101-105, 1990.
Parkhill et al., “Complete DNA sequence of a serogroup a strain ofNeisseria meningitidisZ2491,”Nature404:502-506, 2000.
Roitt et al.,Immunology, 4th Edition, 1998, pp. 7.7-7.8, Mosby, London.
Rokbi et al., “Evaluation of Recombinant Transferrin-Binding Protein B Variants fromNeisseria meningitidisfor Their Ability To Induce Cross-Reactive and Bactericidal Antibodies against a Genetically Diverse Collection of Serogroup B Strains,”Infection and Immunity65(1):55-63, 1997.
Thornton et al., “Location of ‘continuous’ antigenic determinants in the protruding regions of proteins,”EMBO Journal5(2):409-413, 1986.
Defrenne Catherine
Delmelle Christine
Ruelle Jean-Louis
Baskar Padma
GlaxoSmithKline Biologicals S.A.
Mondesi Robert B
Seed IP Group PLLC
LandOfFree
BASB082 Polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BASB082 Polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BASB082 Polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4166035